Question 1

What is CONMED's finite-lived intangible assets - expected amortization expense (year one)?

Accepted Answer

CONMED (CNMD) reported finite-lived intangible assets - expected amortization expense (year one) of $34.51M in Q2 2026.

Question 2

How has CONMED's finite-lived intangible assets - expected amortization expense (year one) changed year-over-year?

Accepted Answer

CONMED's finite-lived intangible assets - expected amortization expense (year one) decreased by 11.8% year-over-year, from $39.11M to $34.51M.

Question 3

What does finite-lived intangible assets - expected amortization expense (year one) mean?

Accepted Answer

This metric forecasts the amortization expense expected to be recognized in the upcoming fiscal year for intangible assets with finite useful lives. It provides visibility into the non-cash earnings impact of previously acquired intangible assets. Analysts use this to refine future earnings projections and cash flow models.

Line item	Amortization included in expense	Amortization recorded as a reduction of revenue	Total
Remaining, 2026	$14,664	$3,000	$17,664
2027	30,374	6,000	36,374
2028	33,829	6,000	39,829
2029	33,023	6,000	39,023
2030	34,505	6,000	40,505
2031	35,935	6,000	41,935

Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) at other companies

Other financials

Income statement

Balance sheet

Cash flow

Valuation

Profitability

Returns & leverage

Where this comes from

FAQ

Ask your AI about CONMED's finite-lived intangible assets - expected amortization expense (year one).

CONMED CNMD Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)